Author

Constanza Ciriza De Los Ríos 1

1 Hospital

A 12-WEEK TREATMENT WITH BUDESONIDE ORODISPERSIBLE TABLETS IN THE EOS-1 TRIAL FOR INCOMPLETE RESPONDERS SIGNIFICANTLY IMPROVES BOTH INFLAMMATORY AND FIBROSTENOTIC ENDOSCOPIC FEATURES IN ADULT PATIENTS WITH ACTIVE EOSINOPHILIC ESOPHAGITIS

Stephan Miehlke, Alfredo J. Lucendo, Christoph Schlag, Ulrike von Arnim, Javier Molina Infante, Christoph Schmöcker, Albert Jan Bredenoord, Constanza Ciriza De Los Ríos, Stefan Brückner, Ahmed Madisch, Stefan Schubert, Jamal Hayat, Stephen E. Attwood, Jan Tack, Ralph Mueller, Roland Greinwald, Alex Straumann, Alain M. Scho

A novel budesonide orodispersible tablet formulation is highly effective to maintain endoscopic inflammatory remission and even complete endoscopic remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Christoph Schlag, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

A novel oral budesonide formulation is highly effective for induction of remission in patients with active eosinophilic esophagitis: Results from the 6-weeks open-label treatment phase of EOS-2 trial

Alfredo J. Lucendo, Christoph Schlag, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Dirk Hartmann, Jamal Hayat, Petr Hruz, Constanza Ciriza De Los Ríos, Arjan Bredenoord, Michael Vieth, Ralph Müller, Roland Greinwald, Alex Straumann

ASSESSMENT OF THE REFLEX RESPONSE OF THE LOWER ESOPHAGEAL SPHINTER THROUGH HIGH RESOLUTION MANOMETRY

Oscar Moralejo Lozano, Julio Antonio Pérez de la Serna y Bueno, Antonio Ruiz de León, Concepción Sevilla Mantilla, Ana Zataraín Valles, Marta Aparicio Cabezudo, Constanza Ciriza De Los Ríos, Adrián Joaquín Barrajón Masa, Michel Colmenares Bulgheroni

BUDESONIDE ORODISPERSIBLE TABLETS ARE ABLE TO MAINTAIN CLINICAL, HISTOLOGICAL AND ENDOSCOPIC REMISSION IN ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE FIRST 48-WEEKS OPEN-LABEL EXTENSION PHASE OF THE 1-YEAR DOUBLE-BLIND EOS-2 TRIAL

Ralph Mueller, Christoph Schlag, Christoph Schmöcker, Roland Greinwald, Luc Biedermann, Michael Vieth, Alfredo J. Lucendo, Cecilio Santander, Alex Straumann, Petr Hruz, Ahmed Madisch, Stephan Miehlke, Stephen E. Attwood, Arjan Bredenoord, Stefan Schubert, Constanza Ciriza De Los Ríos, Alain M. Schoepfer, Jamal Hayat, Ulri

BUDESONIDE ORODISPERSIBLE TABLETS ARE HIGHLY EFFECTIVE FOR RE-INDUCTION OF CLINICAL REMISSION IN RELAPSING ADULT PATIENTS WITH EOSINOPHILIC ESOPHAGITIS: RESULTS FROM THE EOS-2 TRIAL

Christoph Schlag, Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Christoph Schmöcker, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Albert Jan Bredenoord, Ralph Mueller, Roland Greinwald, Alain M. Schoepfer, Stephen E. Attwood, Stefan

Budesonide orodispersible tablets are superior to maintain and even further improve quality of life in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Christoph Schlag, Luc Biedermann, Alfredo J. Lucendo, Stephan Miehlke, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen E. Attwood, Alex Straumann

Budesonide orodispersible tablets are superior to maintain combined clinical and histological remission in adult patients with eosinophilic esophagitis: Results from the 48-weeks, double-blind, placebo-controlled pivotal EOS-2 trial

Alex Straumann, Alfredo J. Lucendo, Stephan Miehlke, Michael Vieth, Christoph Schlag, Luc Biedermann, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Dirk Hartmann, Ahmed Madisch, Petr Hruz, Jamal Hayat, Ulrike von Arnim, Arjan Bredenoord, Stefan Schubert, Ralph Müller, Roland Greinwald, Alain Schoepfer, Stephen

BUDESONIDE ORODISPERSIBLE TABLETS IMPROVE THE ESOPHAGEAL DISTENSIBILITY IN EOSINOPHILIC ESOPHAGITIS: RESULTS FROM SUBSET ANALYSES OF THE RANDOMIZED, DOUBLE-BLIND, MULTICENTER, PLACEBO-CONTROLLED EOS-1 AND EOS-2 TRIALS

Alfredo J. Lucendo, Christoph Schlag, Alex Straumann, Guillermo José Ortega, Ancor Sanz-García, Cecilio Santander Vaquero, Constanza Ciriza De Los Ríos, Ralph Mueller, Roland Greinwald, Stephen Attwood9, Jan Tack

DIAGNOSTIC DELAY REDUCES AND DIAGNOSTIC PRECISION INCREASES ALONG TIME FOR EOSINOPHILIC ESOPHAGITIS: AN ANALYSIS FROM THE EOE CONNECT REGISTRY ON THE IMPACT ON CLINICAL PRACTICE GUIDELINES TO IMPROVE DISEASE AWARENESS IN EUROPE

M Pilar Navarro Sánchez, Emilio Jose Laserna-Mendieta, Danila Guagnozzi, Sergio Casabona-Francés, Maria Antonia Perello, Susana de la Riva, L. Blas-Jhon, Isabel Pérez-Martínez, Jesús Barrio Andrés, Anne Lund Krarup, Antonio Guardiola Arévalo, Javier Alcedo, Carolina Gutiérrez-Junquera, Edoardo Vincenzo Savarino, M.T. Palomequ

Item 1 - 10 / 18
1
2